You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Head and neck cancers

Leukocyte interleukin in combination for neoadjuvant treatment of resectable locally advanced squamous cell head and neck cancer [ID6390]

  • In development
  • Reference number: GID-TA11475
  • Expected publication date: TBC
  • Project information
  • Project documents

NIHRIO BN: 5578-Multikine-with-Cyclophosphamide-Indomethacin-and-Zinc-for-Head-and-Neck-Cancer-V1.0-OCT2023-NON-CONF.pdf (nihr.ac.uk)

Back to top